Zurueck zur Suche

Reporte zur Charge UT6656KA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 1 WI 1

VAERS 981056

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT6656KA

moderat
Staat
MI
Alter
43,0
Geschlecht
F
Eingang
28.01.2021
Impfdatum
09.10.2019
Beginn
10.10.2019
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Magnetic resonance imaging Mobility decreased X-ray

Symptomtext

Severe shoulder pain. Treated with oral steroids followed by physical therapy, a second round of physical therapy (ending in mid January 2020). Pain improved but did not go away. Referred to Doctor (ortho physician) at end of January but COVID delayed appointment until June 2020. MRI ordered (delayed until mid August 2020). Xray guided steroid injection into shoulder September 2020. Pain and shoulder functionality issues resolved until mid November 2020 when all pain returned and continues to worsen.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
MRI August 14 2020 Xray guided injection September 2 2020
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 918165

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT6656KA

gering
Staat
WI
Alter
41,0
Geschlecht
M
Eingang
04.01.2021
Impfdatum
23.12.2020
Beginn
23.12.2020
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Patient received a dose of expired Fluzone Quadrivalent, no AE; Initial information regarding an unsolicited valid non-serious case was received from a nurse practitioner via Medical Information (Reference number- 00405238) and transmitted to Sanofi on 23-Dec-2020. This case involves a 41 years old male patient who was administered with a 0.5 ml standard dose of expired INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (lot number UT6656KA and expiry date 30-Jun-2020) once via unknown route in an unknown administration site for prophylactic vaccination on 23rd December 2020 (Expired product administered). Medical history, past medical treatment(s), vaccination(s), and family history were not provided. No other vaccine was administered concomitantly. This was an actual medication error due to expired vaccine used [latency was same day]. No laboratory data reported. At the time of reporting, no adverse event was reported. Reporter asked for appropriate follow-up after expired dose of Fluzone Quadrivalent was administered. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Potential PTC (product technical complaint)- No

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-